Victims of AIDS must not only combat the virus that causes the disease but must also fend off potentially fatal infections that overrun their weakened immune systems. A team of researchers in Boston and Los Angeles, led by Hematologist Jerome Groopman of New England Deaconess Hospital, reported in the New England Journal of Medicine last week that a genetically engineered version of a naturally occurring hormone partially restored depressed immune systems in 16 AIDS patients.
Known as granulocyte-macrophage colony-stimulating factor, the drug boosted the victims' count of white blood cells, the body's primary defense against infection, after just ten days of...
To continue reading:
or
Log-In
